Pain Medicine And Rehabilitati is categorized under Rehabilitation Center, Outpatient Treatment in Staten Island, NY and active since 2005.
Pain Medicine And Rehabilitati was established in 2005, and today employs 1 to 4, earning Unknown per year. This is a Rehabilitation Center, Outpatient Treatment business, which does work in the B2C market, and is classified as a Rehabilitation Center, Outpatient Treatment, under code number 621498 by the NAICS.
If you are seeking more information, feel free to contact at the company’s single location by writing to 12 Endor Avenue, Staten Island, New York NY 10301 or by phoning (718) 981-8387. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Pain Medicine And Rehabilitati |
Address: | 12 Endor Avenue, Staten Island, New York 10301 |
Phone Number: | (718) 981-8387 |
Annual Revenue (USD): | Unknown |
Founded: | 2005 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Rehabilitation Center, Outpatient Treatment |
SIC Code: | 8093 |
NAICS Code: | 621498 |
Share This Business: |
Pain Medicine And Rehabilitati was started in 2005 to provide professional Rehabilitation Center, Outpatient Treatment under the SIC code 8093 and NAICS code 621498. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact for inquiries that concern Pain Medicine And Rehabilitati by calling the company number (718) 981-8387, as your correspondence is most welcome. Additionally, the physical location of the single location of Pain Medicine And Rehabilitati can be found at the coordinates 40.607907,-74.100773 as well as the street address 12 Endor Avenue in Staten Island, New York 10301.
For its online presence, you may visit Pain Medicine And Rehabilitati’s website at and engage with its social media outlets through on Twitter and on Facebook.